Current and Novel Treatment Options in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer | JCO Oncology Practice ASCO OncoAlert Nerea Lopetegui-Lia, MD Cleveland Clinic IM CCF Hematology Oncology Fellows Cleveland Clinic Erin Roesch ascopubs.org/doi/10.1200/OP…

Congrats Moshe Ornstein MD Cleveland Clinic MD on this novel approach of intermittent IO in mRCc! An area of unmet need. Jame Abraham, MD, FACP Amanda Nizam, MD Christopher Wee, MD Tim Gilligan Kidney Cancer Kidney Cancer Tian Zhang, MD, MHS Sumanta K. Pal, MD, FASCO Brian Rini, MD

Tumor-Infiltrating Lymphocyte (TIL) Therapy my.clevelandclinic.org/podcasts/cance… via @clevelandclinic

Case Study: Patient with Metastatic Urothelial Carcinoma Has No Remaining Evidence of Disease consultqd.clevelandclinic.org/case-study-pat… via @clevelandclinic Tim Gilligan

Huge loss for this family, research community Cleveland Clinic Cleveland Clinic Lerner Research Institute Truly an amazing person, accomplished scientist with nearly 1700 publications, and a remarkable leader! Dedicated VeloSano supporter!! Deep condolences !!

New Cellular and Immunotherapy Service Provides Patients with Standard of Care and Clinical Trial Opportunities for Novel Therapies consultqd.clevelandclinic.org/new-cellular-a… via @clevelandclinic

Two weeks to #ESMO24. Multiple important breast onc trials readouts across disease subtypes, including OS from KN522, DB12, 4y of NATALEE, CAPItello290, phase 1 studies of novel ADCs, IO, targeted drugs, and so much more. The countdown is on. See you soon in Barcelona! 🇪🇸 #bcsm

Addressing the Growing Challenge of Young-Onset Colorectal Cancer: The Importance of an Integrated Multidisciplinary Approach | JCO Oncology Practice ascopubs.org/doi/10.1200/OP… JCO Oncology Practice OncoAlert ASCO

Targeted Therapies, Sequencing Strategies, and Beyond in Metastatic Hormone Receptor–Positive Breast Cancer: ASCO Guideline Clinical Insights | JCO Oncology Practice ascopubs.org/doi/10.1200/OP… JCO Oncology Practice OncoAlert

It was my honor to be at AKMG meeting to deliver the keynote on “Role of doctor in the Age of Fourth Industrial Revolution! “

Our researchers devote countless hours trying to find ways to beat cancer. In this podcast, learn about the work oncologist Jessica Geiger is doing on a vaccine for a type of head and neck cancer thanks to a grant from our VeloSano Bike to Cure event: cle.clinic/3Z75XR1

Study Finds Immunotherapy Increases Three-Year Survival in Adults with B-Cell Precursor Acute Lymphoblastic Leukemia consultqd.clevelandclinic.org/study-finds-im… via @clevelandclinic Hetty Carraway

Excited about ⁦VeloSano⁩ tomorrow! Thank you for your generous support #cancerresearch ⁦Cleveland Clinic⁩ ! ⁦Dale Shepard MD, PhD⁩ ⁦John Suh⁩

Ready for ⁦VeloSano⁩ ? Thank you for the leadership of ⁦Dale Shepard MD, PhD⁩ ⁦ChrisCNP (she/her) 🌈💉💊🩺🩹🩸⁩ !! Thank you for the support of cancer research ⁦Cleveland Clinic⁩

Casual Friday in clinic for ⁦VeloSano⁩!

Yes it is today ⁦VeloSano⁩ !! Thank you for supporting #cancerresearch ⁦Cleveland Clinic⁩ velosano.org ⁦John Suh⁩ ⁦Laura Shoemaker⁩ ⁦Dale Shepard MD, PhD⁩

Already having fun at the VeloSano Kickoff Party promoting #VeloSano and Bike to Cure weekend with Stephanie Haney and WKYC 3News

Rain or shine, we are ready for ⁦VeloSano⁩ ⁦Cleveland Clinic⁩ - Downtown Mall - #Cleveland!

Together, we are a force. Together, we support lifesaving cancer research at Cleveland Clinic. Together, we are making a difference. Thank you to all of our donors, partners, volunteers, fundraisers and riders! Together, we are VeloSano. Together, to cure cancer. #VeloSano

UPDATE: Bike to Cure continues as planned. We are a rain or shine event. Here are some things to note: ➡️All routes and volunteer shifts will start on time ➡️The weather forecast is wet, windy and cool. Please dress accordingly. ➡️Parking lots and shuttles will open at 5:00 a.m.